Developing effective treatments for ultra-rare diseases has long presented a profound paradox for the biopharmaceutical industry and regulatory bodies. While…
Read More
Decoding the Cosmic Mystery of the Ultra High Energy Neutrino Through the Lens of Quasi Extremal Primordial Black Holes
In the autumn of 2023, the scientific community was sent into a state of high alert when a subatomic particle…
Read More
Exploding Primordial Black Holes and the Mystery of the Ultra-High-Energy Neutrino: A New Frontier in Particle Astrophysics
In the vast, silent expanse of the cosmos, particles of nearly unimaginable energy occasionally streak toward Earth, carrying secrets from…
Read More
Exploding Primordial Black Holes and Dark Charge May Solve the Mystery of Ultra-High-Energy Neutrinos and Dark Matter
The detection of a subatomic particle in 2023 sent shockwaves through the global physics community, as a single neutrino struck…
Read More
Rocket Pharmaceuticals Secures Landmark FDA Approval for Kresladi, Ushering in a New Era for Ultra-Rare Immune Disease Treatment
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rocket Pharmaceuticals’ Kresladi (marnetegragene autotemcel), a groundbreaking gene…
Read More
Development of an ultra-sensitive human cardiac troponin I sandwich ELISA
In a significant advancement poised to reshape the landscape of cardiac biomarker detection, Exazym®’s innovative BOLD (Binding Oligo Ladder Detection)…
Read More
